Poltreg S.A.
A clinical-stage biotech developing T-regulatory cell therapies for autoimmune diseases.
PTG | WAR
Overview
Corporate Details
- ISIN(s):
- PLPLTRG00012 (+2 more)
- LEI:
- 259400XSAJTERJ42VZ86
- Country:
- Poland
- Address:
- GDAŃSK BOTANICZNA 20, 80-298 GDAŃSK
- Website:
- https://poltreg.com/
Description
Poltreg S.A. is a clinical-stage biotechnology company developing cellular therapies for a range of autoimmune diseases. The company specializes in treatments based on T-regulatory cells (Tregs), with an advanced pipeline of both polyclonal and engineered cell therapies. Its lead product, PTG-007, is an autologous Treg treatment being investigated for Type 1 Diabetes and Multiple Sclerosis. Poltreg is also advancing next-generation engineered therapies, including Chimeric Antigen Receptor T-regulatory cells (CAR-Tregs), for neuroinflammatory conditions such as Multiple Sclerosis and Amyotrophic Lateral Sclerosis (ALS). The company operates its own state-of-the-art, cGMP-certified manufacturing facility to produce its advanced therapy medicinal products.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Type / Size | Actions | |
|---|---|---|---|---|---|
| 2024-06-25 18:54 |
Rezygnacja Członka Rady Nadzorczej - Content (PL)
|
Polish | HTML • 464 bytes | ||
| 2024-06-25 18:49 |
Wykaz akcjonariuszy posiadających co najmniej 5% głosów na Zwyczajnym Walnym Zg…
|
Polish | HTML • 1.8 KB | ||
| 2024-06-25 18:34 |
sprawozdaie RN o wynagrodzeniach
|
Polish | PDF • 1.0 MB | ||
| 2024-06-25 18:34 |
uchwały
|
Polish | PDF • 251.9 KB | ||
| 2024-06-25 18:34 |
Treść uchwał podjętych przez Zwyczajne Walne Zgromadzenie PolTREG S.A. w dniu 2…
|
Polish | HTML • 656 bytes | ||
| 2024-06-21 10:19 |
Zawarcie umowy współpracy z Uniwersyteckim Centrum Klinicznym - Content (PL)
|
Polish | HTML • 1.9 KB | ||
| 2024-06-19 09:01 |
Wstępne wyniki długookresowych badań w projekcie cukrzycy objawowej - Content (…
|
Polish | HTML • 2.5 KB | ||
| 2024-06-13 11:50 |
Otrzymanie zezwolenia od Ministerstwa Klimatu i Środowiska na prowadzenie zakła…
|
Polish | HTML • 705 bytes | ||
| 2024-05-27 16:39 |
Raport biegłego z oceny sprawozdania o wynagrodzeniach
|
Polish | PDF • 248.3 KB | ||
| 2024-05-27 16:39 |
Sprawozdanie RN o wynagrodzeniach
|
Polish | PDF • 1.0 MB | ||
| 2024-05-27 16:39 |
Sprawozdanie RN z działalności w 2023 r.
|
Polish | PDF • 830.7 KB | ||
| 2024-05-27 16:39 |
Projekty uchwał
|
Polish | PDF • 341.5 KB | ||
| 2024-05-27 16:39 |
Ogłoszenie o zwołaniu
|
Polish | PDF • 259.7 KB | ||
| 2024-05-27 16:39 |
Zwołanie Zwyczajnego Walnego Zgromadzenia PolTREG S.A. na dzień 25 czerwca 2024…
|
Polish | HTML • 812 bytes | ||
| 2024-05-23 17:06 |
Raport kwartalny 1Q 2024
|
Polish | PDF • 6.5 MB |
Automate Your Workflow. Get a real-time feed of all Poltreg S.A. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Poltreg S.A.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Poltreg S.A. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
